Superior Immune Response to Protein-Conjugate versus Free Pneumococcal Polysaccharide Vaccine in Chronic Obstructive Pulmonary Disease

Rationale: Debate exists about the immunogenicity and protective efficacy of antibodies produced by the 23-valent pneumococcal polysaccharide vaccine (PPSV23) in chronic obstructive pulmonary disease (COPD). The 7-valent diphtheria-conjugated pneumococcal polysaccharide vaccine (PCV7) induces a more...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dransfield, Mark T., Nahm, Moon H., Han, MeiLan K., Harnden, Sarah, Criner, Gerard J., Martinez, Fernando J., Scanlon, Paul D., Woodruff, Prescott G., Washko, George R., Connett, John E., Anthonisen, Nicholas R., Bailey, William C.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Thoracic Society 2009
Materias:
B. Chronic Obstructive Pulmonary Disease
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2742743/
https://ncbi.nlm.nih.gov/pubmed/19556517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.200903-0488OC
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares